The role of astrocytes in multiple sclerosis pathogenesis;Participación de los astrocitos en la patogénesis de la esclerosis múltiple

Neurologia

Volumn 35, Issue 6, 2020, Pages 400-408

  Guerrero Garcia J J ^a,b  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

Astrocytes; Blood brain barrier; CNS inflammation; Cytokines; Major histocompatibility complex; Multiple sclerosis

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR;

ASTROCYTE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; HUMAN; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; REVIEW; T LYMPHOCYTE; ANIMAL; INFLAMMATION; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; HUMANS; INFLAMMATION; MICE; MULTIPLE SCLEROSIS; RATS; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 85029827713     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2017.07.021     Document Type: Review

References (95)

1. Noseworthy, J.H., Lucchinetti, C., Rodriguez, M., Weinshenker, B.G., Multiple sclerosis. N Engl J Med. 343 (2000), 938–952.
2. Bruck, W., The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J Neurol. 252:Suppl 5. (2005), v3–v9.
3. Lassmann, H., Multiple sclerosis: Lessons from molecular neuropathology. Exp Neurol. 262:Pt A (2014), 2–7.
4. Disanto, G., Berlanga, A.J., Handel, A.E., Para, A.E., Burrell, A.M., Fries, A., et al. Heterogeneity in multiple sclerosis: Scratching the surface of a complex disease. Autoimmune Dis., 2011, 2010, 932351.
5. Guerrero-Garcia, J.J., Carrera-Quintanar, L., Lopez-Roa, R.I., Marquez-Aguirre, A.L., Rojas-Mayorquin, A.E., Ortuno-Sahagun, D., Multiple sclerosis and obesity: Possible roles of adipokines. Mediators Inflamm., 2016, 2016, 4036232.
6. Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., Lassmann, H., Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol. 47 (2000), 707–717.
7. Sospedra, M., Martin, R., Immunology of multiple sclerosis. Annu Rev Immunol. 23 (2005), 683–747.
8. Steinman, L., Immunology of relapse and remission in multiple sclerosis. Annu Rev Immunol. 32 (2014), 257–281.
9. He, F., Sun, Y.E., Glial cells more than support cells?. Int J Biochem Cell Biol. 39 (2007), 661–665.
10. Correale, J., Farez, M.F., The role of astrocytes in multiple sclerosis progression. Front Neurol., 6, 2015, 180.
11. Moore, C.S., Abdullah, S.L., Brown, A., Arulpragasam, A., Crocker, S.J., How factors secreted from astrocytes impact myelin repair. J Neurosci Res. 89 (2011), 13–21.
12. Farina, C., Aloisi, F., Meinl, E., Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28 (2007), 138–145.
13. Echchannaoui, H., Frei, K., Schnell, C., Leib, S.L., Zimmerli, W., Landmann, R., Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis. 186 (2002), 798–806.
14. Shen, Y., Kawamura, I., Nomura, T., Tsuchiya, K., Hara, H., Dewamitta, S.R., et al. Toll-like receptor 2- and MyD88-dependent phosphatidylinositol 3-kinase and Rac1 activation facilitates the phagocytosis of Listeria monocytogenes by murine macrophages. Infect Immun. 78 (2010), 2857–2867.
15. Kurt-Jones, E.A., Chan, M., Zhou, S., Wang, J., Reed, G., Bronson, R., et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A. 101 (2004), 1315–1320.
16. Poteet, E., Lewis, P., Chen, C., Ho, S.O., Do, T., Chiang, S., et al. Toll-like receptor 3 adjuvant in combination with virus-like particles elicit a humoral response against HIV. Vaccine. 34 (2016), 5886–5894.
17. Prinz, M., Garbe, F., Schmidt, H., Mildner, A., Gutcher, I., Wolter, K., et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest. 116 (2006), 456–464.
18. Chattopadhyay, S., Sen, G.C., dsRNA-activation of TLR3 and RLR signaling: Gene induction-dependent and independent effects. J Interferon Cytokine Res. 34 (2014), 427–436.
19. Kawai, T., Akira, S., Antiviral signaling through pattern recognition receptors. J Biochem. 141 (2007), 137–145.
20. Bsibsi, M., Persoon-Deen, C., Verwer, R.W., Meeuwsen, S., Ravid, R., van Noort, J.M., Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia. 53 (2006), 688–695.
21. Farina, C., Krumbholz, M., Giese, T., Hartmann, G., Aloisi, F., Meinl, E., Preferential expression and function of Toll-like receptor 3 in human astrocytes. J Neuroimmunol. 159 (2005), 12–19.
22. Andersson, A., Covacu, R., Sunnemark, D., Danilov, A.I., dal Bianco, A., Khademi, M., et al. Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol. 84 (2008), 1248–1255.
23. Crowley, T., Fitzpatrick, J.M., Kuijper, T., Cryan, J.F., O'Toole, O., O'Leary, O.F., et al. Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: Relevance to therapeutic effects in multiple sclerosis. Front Cell Neurosci., 9, 2015, 284.
24. Chastain, E.M., Duncan, D.S., Rodgers, J.M., Miller, S.D., The role of antigen presenting cells in multiple sclerosis. Biochim Biophys Acta. 1812 (2011), 265–274.
25. Sofroniew, M.V., Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci. 16 (2015), 249–263.
26. Massa, P.T., Ozato, K., McFarlin, D.E., Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia. 8 (1993), 201–207.
27. Gresser, O., Hein, A., Riese, S., Regnier-Vigouroux, A., Tumor necrosis factor alpha and interleukin-1 alpha inhibit through different pathways interferon-gamma-induced antigen presentation, processing and MHC class II surface expression on astrocytes, but not on microglia. Cell Tissue Res. 300 (2000), 373–382.
28. Hamo, L., Stohlman, S.A., Otto-Duessel, M., Bergmann, C.C., Distinct regulation of MHC molecule expression on astrocytes and microglia during viral encephalomyelitis. Glia. 55 (2007), 1169–1177.
29. Vidovic, M., Sparacio, S.M., Elovitz, M., Benveniste, E.N., Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-gamma and tumor necrosis factor-alpha. J Neuroimmunol. 30 (1990), 189–200.
30. Zeinstra, E., Wilczak, N., de Keyser, J., Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2. J Neuroimmunol. 135 (2003), 166–171.
31. Soos, J.M., Ashley, T.A., Morrow, J., Patarroyo, J.C., Szente, B.E., Zamvil, S.S., Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production. Int Immunol. 11 (1999), 1169–1179.
32. Cross, A.H., Ku, G., Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis. J Neuroimmunol. 110 (2000), 76–82.
33. Satoh, J., Lee, Y.B., Kim, S.U., T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Res. 704 (1995), 92–96.
34. Liu, Y., King, N., Kesson, A., Blanden, R.V., Mullbacher, A., Flavivirus infection up-regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro. J Neuroimmunol. 21 (1989), 157–168.
35. Hirayama, M., Miyadai, T., Yokochi, T., Sato, K., Kubota, T., Iida, M., et al. Infection of human T-lymphotropic virus type I to astrocytes in vitro with induction of the class II major histocompatibility complex. Neurosci Lett. 92 (1988), 34–39.
36. Vardjan, N., Gabrijel, M., Potokar, M., Svajger, U., Kreft, M., Jeras, M., et al. IFN-gamma-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments. J Neuroinflammation., 9, 2012, 144.
37. Jarosinski, K.W., Massa, P.T., Interferon regulatory factor-1 is required for interferon-gamma-induced MHC class I genes in astrocytes. J Neuroimmunol. 122 (2002), 74–84.
38. Morga, E., Heuschling, P., Interleukin-4 down-regulates MHC class II antigens on cultured rat astrocytes. Glia. 17 (1996), 175–179.
39. Ransohoff, R.M., Estes, M.L., Astrocyte expression of major histocompatibility complex gene products in multiple sclerosis brain tissue obtained by stereotactic biopsy. Arch Neurol. 48 (1991), 1244–1246.
40. Frank, E., Pulver, M., de Tribolet, N., Expression of class II major histocompatibility antigens on reactive astrocytes and endothelial cells within the gliosis surrounding metastases and abscesses. J Neuroimmunol. 12 (1986), 29–36.
41. Zeinstra, E., Wilczak, N., Streefland, C., de Keyser, J., Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules. Neuroreport. 11 (2000), 89–91.
42. Hirayama, M., Yokochi, T., Shimokata, K., Iida, M., Fujiki, N., Induction of human leukocyte antigen-A, B C and -DR on cultured human oligodendrocytes and astrocytes by human gamma-interferon. Neurosci Lett. 72 (1986), 369–374.
43. Pulver, M., Carrel, S., Mach, J.P., de Tribolet, N., Cultured human fetal astrocytes can be induced by interferon-gamma to express HLA-DR. J Neuroimmunol. 14 (1987), 123–133.
44. Panek, R.B., Lee, Y.J., Itoh-Lindstrom, Y., Ting, J.P., Benveniste, E.N., Characterization of astrocyte nuclear proteins involved in IFN-gamma- and TNF-alpha-mediated class II MHC gene expression. J Immunol. 153 (1994), 4555–4564.
45. Barna, B.P., Chou, S.M., Jacobs, B., Yen-Lieberman, B., Ransohoff, R.M., Interferon-beta impairs induction of HLA-DR antigen expression in cultured adult human astrocytes. J Neuroimmunol. 23 (1989), 45–53.
46. Satoh, J., Paty, D.W., Kim, S.U., Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes. Neurology. 45 (1995), 367–373.
47. Kurtuncu, M., Tuzun, E., Turkoglu, R., Petek-Balci, B., Icoz, S., Pehlivan, M., et al. Effect of short-term interferon-beta treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23. Cytokine. 59 (2012), 400–402.
48. Dressel, A., Kolb, A.K., Elitok, E., Bitsch, A., Bogumil, T., Kitze, B., et al. Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis. Acta Neurol Scand. 114 (2006), 368–373.
49. Khademi, M., Wallstrom, E., Andersson, M., Piehl, F., di Marco, R., Olsson, T., Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis. J Neuroimmunol. 103 (2000), 202–210.
50. Loma, I., Heyman, R., Multiple sclerosis: Pathogenesis and treatment. Curr Neuropharmacol. 9 (2011), 409–416.
51. Schluesener, H.J., Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha. J Neuroimmunol. 27 (1990), 41–47.
52. Lee, Y.J., Han, Y., Lu, H.T., Nguyen, V., Qin, H., Howe, P.H., et al. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J Immunol. 158 (1997), 2065–2075.
53. Czarniecki, C.W., Chiu, H.H., Wong, G.H., McCabe, S.M., Palladino, M.A., Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. J Immunol. 140 (1988), 4217–4223.
54. Reimold, A.M., Kara, C.J., Rooney, J.W., Glimcher, L.H., Transforming growth factor beta 1 repression of the HLA-DR alpha gene is mediated by conserved proximal promoter elements. J Immunol. 151 (1993), 4173–4182.
55. Dong, Y., Tang, L., Letterio, J.J., Benveniste, E.N., The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression. J Immunol. 167 (2001), 311–319.
56. Stuve, O., Youssef, S., Slavin, A.J., King, C.L., Patarroyo, J.C., Hirschberg, D.L., et al. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J Immunol. 169 (2002), 6720–6732.
57. Lee, S.C., Collins, M., Vanguri, P., Shin, M.L., Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia. J Immunol. 148 (1992), 3391–3397.
58. Frohman, E.M., Vayuvegula, B., van den Noort, S., Gupta, S., Norepinephrine inhibits gamma-interferon-induced MHC class II (Ia) antigen expression on cultured brain astrocytes. J Neuroimmunol. 17 (1988), 89–101.
59. Massa, P.T., Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides. J Exp Med. 178 (1993), 1357–1363.
60. Massa, P.T., Wu, C., Modulation of major histocompatibility complex class I genes by interferon-gamma and ganglioside GT 1b in astrocytes: Involvement of protein tyrosine phosphatases. J Neurochem. 67 (1996), 1831–1839.
61. Abdouh, M., Storring, J.M., Riad, M., Paquette, Y., Albert, P.R., Drobetsky, E., et al. Transcriptional mechanisms for induction of 5-HT1A receptor mRNA and protein in activated B and T lymphocytes. J Biol Chem. 276 (2001), 4382–4388.
62. Sternberg, E.M., Trial, J., Parker, C.W., Effect of serotonin on murine macrophages: Suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. J Immunol. 137 (1986), 276–282.
63. Zeinstra, E.M., Wilczak, N., Wilschut, J.C., Glazenburg, L., Chesik, D., Kroese, F.G., et al. 5HT4 agonists inhibit interferon-gamma-induced MHC class II and B7 costimulatory molecules expression on cultured astrocytes. J Neuroimmunol. 179 (2006), 191–195.
64. Seddighzadeh, M., Korotkova, M., Kallberg, H., Ding, B., Daha, N., Kurreeman, F.A., et al. Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2 A and MHC type II molecules in the development of rheumatoid arthritis. Eur J Hum Genet. 18 (2010), 821–826.
65. Kostic, M., Zivkovic, N., Cvetanovic, A., Stojanovic, I., Colic, M., IL-17 signalling in astrocytes promotes glutamate excitotoxicity: Indications for the link between inflammatory and neurodegenerative events in multiple sclerosis. Mult Scler Relat Disord. 11 (2017), 12–17.
66. Karki, P., Smith, K., Johnson, J. Jr., Lee, E., Astrocyte-derived growth factors and estrogen neuroprotection: Role of transforming growth factor-alpha in estrogen-induced upregulation of glutamate transporters in astrocytes. Mol Cell Endocrinol. 389 (2014), 58–64.
67. Chakrabarti, M., Haque, A., Banik, N.L., Nagarkatti, P., Nagarkatti, M., Ray, S.K., Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull. 109 (2014), 22–31.
68. Adamski, J., Ma, Z., Nozell, S., Benveniste, E.N., 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: Influence on histone modifications and cbp recruitment to the class II MHC promoter. Mol Endocrinol. 18 (2004), 1963–1974.
69. Dimayuga, F.O., Reed, J.L., Carnero, G.A., Wang, C., Dimayuga, E.R., Dimayuga, V.M., et al. Estrogen and brain inflammation: Effects on microglial expression of MHC, costimulatory molecules and cytokines. J Neuroimmunol. 161 (2005), 123–136.
70. Polanczyk, M.J., Hopke, C., Vandenbark, A.A., Offner, H., Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J Neurosci Res. 84 (2006), 370–378.
71. Abbott, N.J., Ronnback, L., Hansson, E., Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 7 (2006), 41–53.
72. Brand-Schieber, E., Werner, P., Iacobas, D.A., Iacobas, S., Beelitz, M., Lowery, S.L., et al. Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis. J Neurosci Res. 80 (2005), 798–808.
73. Sinclair, C., Kirk, J., Herron, B., Fitzgerald, U., McQuaid, S., Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol. 113 (2007), 187–194.
74. Soltani, Z., Khaksari, M., Shahrokhi, N., Mohammadi, G., Mofid, B., Vaziri, A., et al. Effect of estrogen and/or progesterone administration on traumatic brain injury-caused brain edema: The changes of aquaporin-4 and interleukin-6. J Physiol Biochem. 72 (2016), 33–44.
75. Nair, A., Frederick, T.J., Miller, S.D., Astrocytes in multiple sclerosis: A product of their environment. Cell Mol Life Sci. 65 (2008), 2702–2720.
76. Banks, W.A., Blood-brain barrier transport of cytokines: A mechanism for neuropathology. Curr Pharm Des. 11 (2005), 973–984.
77. Kang, Z., Wang, C., Zepp, J., Wu, L., Sun, K., Zhao, J., et al. Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells. Nat Neurosci. 16 (2013), 1401–1408.
78. Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 13 (2007), 1173–1175.
79. Damsker, J.M., Hansen, A.M., Caspi, R.R., Th1 and Th17 cells: Adversaries and collaborators. Ann N Y Acad Sci. 1183 (2010), 211–221.
80. Constantinescu, C.S., Frei, K., Wysocka, M., Trinchieri, G., Malipiero, U., Rostami, A., et al. Astrocytes and microglia produce interleukin-12 p40. Ann N Y Acad Sci. 795 (1996), 328–333.
81. Constantinescu, C.S., Tani, M., Ransohoff, R.M., Wysocka, M., Hilliard, B., Fujioka, T., et al. Astrocytes as antigen-presenting cells: Expression of IL-12/IL-23. J Neurochem. 95 (2005), 331–340.
82. Senecal, V., Deblois, G., Beauseigle, D., Schneider, R., Brandenburg, J., Newcombe, J., et al. Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses. Glia. 64 (2016), 553–569.
83. Hunter, C.A., New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol. 5 (2005), 521–531.
84. Aggarwal, S., Ghilardi, N., Xie, M.H., de Sauvage, F.J., Gurney, A.L., Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 278 (2003), 1910–1914.
85. Becher, B., Durell, B.G., Noelle, R.J., Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest. 110 (2002), 493–497.
86. Gran, B., Zhang, G.X., Yu, S., Li, J., Chen, X.H., Ventura, E.S., et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol. 169 (2002), 7104–7110.
87. Kostic, M., Dzopalic, T., Zivanovic, S., Zivkovic, N., Cvetanovic, A., Stojanovic, I., et al. IL-17 and glutamate excitotoxicity in the pathogenesis of multiple sclerosis. Scand J Immunol. 79 (2014), 181–186.
88. Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy, K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 6 (2005), 1123–1132.
89. Lee, E.S., Sidoryk, M., Jiang, H., Yin, Z., Aschner, M., Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes. J Neurochem. 110 (2009), 530–544.
90. Pawlak, J., Brito, V., Kuppers, E., Beyer, C., Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res Mol Brain Res. 138 (2005), 1–7.
91. Liang, Z., Valla, J., Sefidvash-Hockley, S., Rogers, J., Li, R., Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J Neurochem. 80 (2002), 807–814.
92. Lee, E., Sidoryk-Wegrzynowicz, M., Yin, Z., Webb, A., Son, D.S., Aschner, M., Transforming growth factor-alpha mediates estrogen-induced upregulation of glutamate transporter GLT-1 in rat primary astrocytes. Glia. 60 (2012), 1024–1036.
93. Batten, M., Li, J., Yi, S., Kljavin, N.M., Danilenko, D.M., Lucas, S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol. 7 (2006), 929–936.
94. Stumhofer, J.S., Laurence, A., Wilson, E.H., Huang, E., Tato, C.M., Johnson, L.M., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol. 7 (2006), 937–945.
95. Stumhofer, J.S., Silver, J.S., Laurence, A., Porrett, P.M., Harris, T.H., Turka, L.A., et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol. 8 (2007), 1363–1371.